Medical treatment of patients with stable angina pectoris referred for coronary angiography: Failure of treatment or failure to treat

被引:9
作者
Carasso, S
Markiewicz, W
机构
[1] Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Sch Med, Haifa, Israel
关键词
angina; angiogyraphy; catheterization; coronary disease; drugs; risk factors;
D O I
10.1002/clc.4960250908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients referred for elective coronary arteriography because of stable angina pectoris frequently do not receive appropriate medical therapy prior to arteriography. Persistence of symptoms due to lack of appropriate therapy may influence the decision to catheterize and the treatment chosen following catheterization. Hypothesis: The present study evaluates whether patients with stable angina pectoris referred for cardiac catheterization received optimal therapy prior to the procedure. We also evaluated whether medical therapy was optimized as a result of the hospitalization for catherization. Methods: We evaluated prospectively the adequacy of medical therapy in 333 consecutive patients undergoing elective coronary arteriography. Of these, 160 had stable angina pectoris as their main problem and constituted the study group. Results: Mean duration of angina was 7.5 +/- 6.3 months. Canadian Cardiovascular Society angina grade I was present in 20, grade 2 in 77, grade 3 or 4 in 63 patients. Arteriography showed a greater than or equal to 50% coronary stenosis in 141 of 160 patients. Aspirin was used by 96%, and 86% received at least one drug aimed at relieving anginal symptoms: beta blockers in 69%, calcium blockers in 30%, and long-acting nitrates in 29%. Antianginal drugs and drugs aimed at treating risk factors were usually taken at a low, subtherapeutic dosage. Only 35 of 110 patients taking beta blockers had a resting heart rate of less than or equal to 60/min. Following catheterization, 88 of 141 patients with coronary stenosis of greater than or equal to 50% underwent percutanous intervention and 5 had urgent surgery. Optimization of treatment was advised in only 7 of 48 patients for whom medical therapy or elective surgery was recommended. Conclusion: Patients with stable angina pectoris are frequently referred for cardiac catheterization without making a serious attempt to control their symptoms by medical therapy. Risk factors are undertreated. With proper pharmacotherapy, many patients might have become asymptomatic and have chosen not to undergo catheterization and subsequent percutaneous interventions.
引用
收藏
页码:436 / 441
页数:6
相关论文
共 39 条
  • [31] Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals
    Phillips, BG
    Yim, JM
    Brown, EJ
    Bittar, N
    Hoon, TJ
    Celestin, C
    Vlasses, PH
    Bauman, JL
    [J]. AMERICAN HEART JOURNAL, 1996, 131 (05) : 872 - 878
  • [32] Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
    Pitt, B
    Waters, D
    Brown, WV
    van Boven, AJ
    Schwartz, L
    Title, LM
    Eisenberg, D
    Shurzinske, L
    McCormick, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (02) : 70 - 76
  • [33] RUBOWITZ AH, 1992, ISRAEL J MED SCI, V28, P856
  • [34] Intensity of antianginal therapy in patients referred for coronary angiography: A comparison of fee-for-service and health maintenance organization therapeutic strategies
    Samuels, BA
    Diamond, GA
    Mahrer, PR
    Denton, TA
    [J]. CLINICAL CARDIOLOGY, 2000, 23 (03) : 165 - 170
  • [35] Effect of local medical opinion leaders on quality of care for acute myocardial infarction - A randomized controlled trial
    Soumerai, SB
    McLaughlin, TJ
    Gurwitz, JH
    Guadagnoli, E
    Hauptman, PJ
    Borbas, C
    Morris, N
    McLaughlin, B
    Gao, XM
    Willison, DJ
    Asinger, R
    Gobel, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (17): : 1358 - 1363
  • [36] VAMAUSKAS E, 1988, NEW ENGL J MED, V319, P332
  • [37] TREATMENT WITH BETA-ADRENERGIC BLOCKING-AGENTS AFTER MYOCARDIAL-INFARCTION - FROM RANDOMIZED TRIALS TO CLINICAL-PRACTICE
    VISKIN, S
    KITZIS, I
    LEV, E
    ZAK, Z
    HELLER, K
    VILLA, Y
    ZAJARIAS, A
    LANIADO, S
    BELHASSEN, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (06) : 1327 - 1332
  • [38] National patterns and predictors of β-blocker use in patients with coronary artery disease
    Wang, TJ
    Stafford, RS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (17) : 1901 - 1906
  • [39] Werner P, 2000, ISRAEL MED ASSOC J, V2, P361